FDA Clears Immunoglobulin Eye Drops for Phase II Dry Eye Trial
Biologic therapy enters clinical study to assess broad anti-inflammatory potential The U.S. FDA has granted IND clearance for a new…
Harrow Expands VEVYE Access for All Program, Offering $59 FDA-Approved Dry Eye Treatment
FDA-approved dry eye relief—no hurdles, no headaches, just $59 a bottle with VEVYE Access for All. On April 10, 2025,…
latest posts